Wis. Admin. Code § CSB 2.015 – Addition of 7 Synthetic Benzimidazole-Opioids to Schedule I.

Section 961.14 (2) (xm) 1m., 5m., 5p., 7b., 7h., 7k., and 8b. are created to read:

961.14 (2) (xm) 1m. Ethyleneoxynitazene (2-(2-((2,3-dihydrobenzofuran-5-yl)methyl)-5-nitro-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine).

5m. Methylenedioxynitazene or 3’,4’-methylenedioxynitazene (2-(2-(benzodioxol-5-ylmethyl)-5-nitro-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine).

5p. 5-methyl etodesnitazene (2-(2-(4-ethoxybenzyl)-5-methyl-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine).

7b. N-desethyl etonitazene (2-(2-(4-ethoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)-N-ethyethan-1-amine).

7h. N-desethyl protonitazene (N-ethyl-2-(5-nitro-2-(4-propoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-amine).

7k. N,N-dimethylamino etonitazene (2-(2-(4-ethoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)-N,N-dimethylethan-1-amine).

8b. N-pyrrolidino isotonitazene (2-(4-isopropoxybenzyl)-5-nitro-1-(2-(pyrrolindin-1-yl)ethyl)-1H-benzimidazole).

History: cr. affirmative action order under s. 961.11 (4), Stats., Register December 2025 No. 840, eff. 12-8-25; renum. (1) to CSB 2.015 under s. 13.92 (4) (b) 1., Stats., Register December 2025 No. 840.